Oncternal Therapeutics grants clinical science head options for 70K shares

da-kuk/E+ via Getty Images

• Oncternal Therapeutics (NASDAQ:ONCT) granted options to buy 70K common shares to its new employee Ted Shih, who joined as head, Clinical Science.
• The award was made on June 1 under Oncternal's 2021 Employment Inducement Incentive Award Plan, and can be exercised at $1.56 per share, which was the closing price of the company's common stock on the date of the grant (June 1).